Orexo expands further - broadens operations and recruits new employees
During 2004, Orexo has grown from 19 to 24 employees, and the company's portfolio of development projects has been expanded and advanced further. Concurrently, development of a new analytical laboratory has been initiated, in line with Orexo's ambition to reach long term profitability through sound and balanced growth, and to become a leading company in drug delivery.
"We are in an expansive phase with a number of projects in various stages of development and new projects under assessment. Our organization has been strengthened with additional expertise, to further development of these projects at an ambitious pace," says Zsolt Lavotha, CEO of Orexo. "At the same time we have built our own analytical laboratory, which is scheduled to become operational during first half of 2005. Due to this new construction, we can expand operations cost-efficiently while concurrently maintaining control of the development process. This will facilitate our ability to achieve our goal of delivering growth and profitability."
Most read news
Other news from the department manufacturing
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.